| Excerpt | Relevance | Reference |
|---|
| "In this study, the authors sought to define the differences in the incidence of delayed cerebral ischemia (DCI) between patients treated with dapsone and those treated with placebo." | 9.51 | Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial. ( Balcázar-Padrón, JC; Díaz-Ruíz, A; García-Pastor, C; Nathal, E; Navarro-Garcia de Llano, JP; Rios, C; Rodríguez-Hernandez, LA; Tristán-López, L, 2022) |
| "In this study, the authors sought to define the differences in the incidence of delayed cerebral ischemia (DCI) between patients treated with dapsone and those treated with placebo." | 5.51 | Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial. ( Balcázar-Padrón, JC; Díaz-Ruíz, A; García-Pastor, C; Nathal, E; Navarro-Garcia de Llano, JP; Rios, C; Rodríguez-Hernandez, LA; Tristán-López, L, 2022) |